Current position:Home >Product >
platinum(2+) cyclohexane-1,2-diyldiazanide - bromoacetic acid (1:1:2)
platinum(2+) cyclohexane-1,2-diyldiazanide - bromoacetic acid (1:1:2)(66900-66-1)
- Name: platinum(2+) cyclohexane-1,2-diyldiazanide - bromoacetic acid (1:1:2)
- Synonyms:Platinum,bis(bromoacetato-O)(1,2-cyclohexanediamine-N,N')-, [SP-4-2-(1S-trans)]-;1,2-Cyclohexanediamine, platinum complex, (1S-trans)-; Acetic acid, bromo-,platinum complex; NSC 289546
- Molecular Formula:C10H18 Br2 N2 O4 Pt
- Molecular Weight:585.1529
- CAS Registry Number:66900-66-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.66900-66-1 Platinum,bis(bromoacetato-kO)[(1S,2S)-1,2-cyclohexanediamine-kN,kN']-, (SP-4-2)- (9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.66900-66-1 66900-66-1
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 68918-76-3/Polyphosphoric acids, Et esters, compds. with ethanolamine
- 29466-38-4/DIHYDROCHOLESTEROL
- 23899-79-8/5-amino-1-methylpyrimidine-2,4(1H,3H)-dione
- 21083-90-9/Hydrazinecarboximidamide,2-[(4-methylphenyl)phenylmethylene]-, hydrochloride (1:1)
- 143729-89-9/(2S,5R,6R)-6-{[({(2E)-2-[2-(biphenyl-4-ylcarbonyl)hydrazinylidene]acetyl}amino)(phenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- 7149-67-9/2-Quinoxalinecarboxamide,N,N'-[1,5-pentanediylbis[imino(2-oxo-2,1-ethanediyl)]]bis- (9CI)
- 31321-62-7/benzyl L-histidinate dihydrochloride
- 25110-41-2/1-phenyl-3-(piperidin-1-yl)pyrrolidine-2,5-dione
- 19812-58-9/N,N-dibenzyl-beta-alanine
- 40986-94-5/1-(4-fluorophenyl)-4-{4-[2-(4-methoxyphenoxy)ethyl]piperazin-1-yl}butan-1-one dihydrochloride
- 14125-96-3/Gibbane-1,10-dicarboxylicacid, 4a-hydroxy-1,7-dimethyl-8-oxo-, 1,4a-lactone, (1a,4aa,4bb,7b,9ab,10b)- (9CI)
- 141319-23-5/mambin
- 65981-17-1/Cholest-4-eno[6,5,4-cd]isoxazole(9CI)
- 930-81-4/1-Lithionorbornane
- 90583-07-6/Sulfuric acid, lead(2+)salt, basic (9CI)
- 64759-44-0/1-methyl-3-(1-methyl-2,5-dioxoimidazolidin-4-yl)urea
- 81865-19-2/methyl {4-[(1-methylethyl)sulfamoyl]phenyl}carbamate
- 7238-19-9/dichlororuthenium(2+) 2-[(E)-cyclohexyldiazenyl]piperidin-1-ide 2-[(E)-cyclohexyldiazenyl]-2H-pyridin-1-ide
- 66900-66-1/platinum(2+) cyclohexane-1,2-diyldiazanide - bromoacetic acid (1:1:2)
- 25384-84-3/[2-({[(2E)-but-2-en-1-ylcarbamoyl]oxy}methyl)-2-methylpentyl]carbamic acid
- 6337-11-7/1-amino-6-iodoanthracene-9,10-dione
- 22280-56-4/2-Chloro-3-methyl-5-nitropyridine
- 131577-81-6/Lenefilcon A [USAN]
- 150375-23-8/Bicyclo[5.1.0]oct-2-ene-2-aceticacid, 3-acetyl-1,5,5-trimethyl-, methyl ester, (1R,7S)-
- 22431-61-4/1-dibenzo[b,f]oxepin-10-yl-4-methylpiperazine (2E)-but-2-enedioate
- 17950-94-6/DIPHENYLSILANE-D2
- 126005-66-1/Kaur-16-en-15-one,12,14,18-trihydroxy-, (4b,12a,14R)- (9CI)
- 7463-68-5/2,3-dimethyl-6,7-dinitrosoquinoxaline
- 82709-34-0/Fazeolin
- 34879-37-3/2,2-dimethylimidazolidine-4,5-dione